News | Magnetic Resonance Imaging (MRI) | May 03, 2017

MR Solutions Wins Second Straight Queen's Award for Enterprise in the U.K.

Cryogen-free preclinical MRI systems help reduce costs, eliminate cumbersome cooling and venting equipment

MR Solutions Wins Second Straight Queen's Award for Enterprise in the U.K.

May 3, 2017 — MR Solutions won the prestigious Queen’s Award for Enterprise for International Trade in late April. These awards are announced on the Queen’s birthday, April 21, and are one of the U.K.’s highest accolades recognizing business achievement. Last year MR Solutions won the Queen’s Award for Innovation.

This has been achieved in recognition of MR Solutions’ business success, with strong export sales growth of 119 percent over the last three years. The company said this success has been driven by its investment in the development and commercialization of their cryogen-free preclinical magnetic resonance imaging (MRI) technology that can be combined with other imaging capabilities such as positron emission tomography (PET) or single-photon emission computed tomography (SPECT). 

Cryogen-free has many advantages for the researchers, not the least being cost. These advantages include doing away with the cumbersome helium cooling jacket and the emergency venting equipment that was necessary to vent the helium should the magnet quench.  It also does away with the extensive building works involved in installing the venting system and these very large machines. The cryogen-free scanner can just be wheeled in.

MR Solutions was able to develop an MRI system using a novel magnet design that only needs a readily available cryocooler unit to get to the very low temperature required. The company’s 3T to 9.4T MRI benchtop scanners are used in research laboratories across the world and can be installed alongside other equipment because the innovative design has reduced the stray magnetic field from meters to centimeters.

For more information: www.mrsolutions.com

Related Content

This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
Fans of Opposing Soccer Teams Perceive Games Differently

Image courtesy of University of York

News | Neuro Imaging | October 25, 2018
Scientists have scanned the brains of die-hard soccer fans to find out why supporters of rival teams often have very...
IMRIS, Siemens Strengthen Collaboration in Hybrid OR Neurosurgical Market
News | Hybrid OR | October 24, 2018
IMRIS, Deerfield Imaging, in partnership with Siemens Healthineers, announced a strengthened collaboration to advance...
Carotid Artery MRI Improves Cardiovascular Disease Risk Assessment
News | Magnetic Resonance Imaging (MRI) | October 23, 2018
Magnetic resonance imaging (MRI) measurements of wall thickness in the carotid arteries improve cardiovascular disease...
The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

Feature | ASTRO | October 20, 2018 | By Greg Freiherr
A linear accelerator combined with high-field MRI could soon be on the U.S. market. If U.S.
FDA Clears Magnetom Sola 1.5T MRI From Siemens Healthineers
Technology | Magnetic Resonance Imaging (MRI) | October 09, 2018
The U.S. Food and Drug Administration (FDA) has cleared the Magnetom Sola, a 1.5 Tesla magnetic resonance imaging (MRI...
ViewRay and Miami Cancer Institute Host Symposium on MR-Guided Radiation Therapy
News | Image Guided Radiation Therapy (IGRT) | October 05, 2018
October 5, 2018 — Leading oncology experts from around the world recently met to discuss the integration of...